Research Paper Volume 12, Issue 8 pp 7112—7128

Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling

Figure 7. (A) Kruskal-Wallis test of expression (FPKM) of 6 ICGs on IDH mutation status; (B) Kruskal-Wallis test of expression (FPKM) of 6 ICGs on PRS type.